Modified citrus pectin anti-metastatic properties: one bullet, multiple targets

Vladislav V Glinsky1, Avraham Raz

  • 1Harry S. Truman Memorial Veterans' Hospital, Columbia, MO 65201, USA.

Carbohydrate Research
|December 9, 2008
PubMed
Summary

Modified citrus pectin (MCP) shows potential in cancer treatment by inhibiting metastasis and enhancing chemotherapy effects. This carbohydrate-based substance may offer new therapeutic strategies for various human malignancies.